New Mexico Heart Institute announced today that Kwabena Mawulawde, MD, FACS, FACC, FCCP, FAHA, has joined its cardiothoracic surgery team.
Mawulawde comes to NMHI from the Cleveland Clinic Health System in Cleveland, Ohio where he was a clinical associate in thoracic and cardiovascular surgery. He is board certified in surgery and thoracic surgery.
“Dr. Mawulawde brings a high level expertise to NMHI and specializes in the care of patients who have complex valvular heart disease,” said Dr. Sean Mazer, President of NMHI’s Board of Directors. “New Mexico Heart Institute has a successful history in cardiac surgery and we are committed to advancing cardiac patient care and research. Dr. Mawulawde is an outstanding addition to our heart team’s program of cardiac excellence.”
Dr. Mawulawde specializes in the following procedures:
- Re-operative (multiple) open heart surgery
- Aortic valve sparing surgery
- Aortic valve repair/replacement (minimally invasive)
- Mitral valve repair/replacement
- Coronary artery bypass grafting
- Surgery for atrial fibrillation
- Myectomy for hypertrophic obstructive cardiomyopathy
- Mechanical circulatory support
- Treatment of pulmonary diseases including transplantation
Mawulawde received his medical degree and completed his residency in general surgery at State University of New York School of Medicine in Buffalo, N.Y. He completed his cardiothoracic residency and his research fellowship at Case-Western Reserve University in Cleveland, OH.
He also fulfilled a special fellowship in Heart, Lung, Heart-Lung Transplantation and mechanical assist devices at Loyola Medical School in Maywood, Ill., and was a National Institutes of Health Fellow/Investigator at the Transplantation Biology Research Center at Massachusetts General Hospital and Harvard Medical School.
Mawulawde joins the surgical team of Brian Castlemain, MD and L. Jane McKinnon, MD, both cardiothoracic surgeons and Steve Henao, MD, a vascular surgeon. Over 250 heart and vascular surgeries are performed at NMHI per year.
ALBUQUERQUE, NM (November 11, 2014) Sean Mazer, MD, an electrophysiologist at New Mexico Heart Institute is the first physician in the Southwest to use an innovative new technology to treat patients with heart rhythm disorders. The procedure took place on a 31-year-old patient on November 3at the Heart Hospital of New Mexico at Lovelace Medical Center. He was cured with the first application of radio frequency energy. This patient had suffered from a long-standing heart rhythm disorder which was life threatening.
The TactiCath Quartz irrigated ablation catheter is a thin, flexible wire threaded through the patient’s veins into their heart. It is used to help treat irregular heartbeats that impair heart’s ability to effectively pump blood throughout the body. This technology is designed to provide the surgeon with a direct measurement of the force the catheter applies to a patient’s heart in order to create more effective burns during an ablation procedure.
“The number of patients with atrial fibrillation is increasing,” said Dr. Mazer, “It’s important for us to use new world class treatments and technologies that increase the efficiency and effectiveness of ablation therapies to treat Afib and improve the quality of care for our patients impacted by this condition.”
The device is the latest ablation therapy from St. Jude Medical and provides electrophysiologists the ability to monitor the amount of pressure that a catheter tip exerts on the endocardium (the layer of tissue that lines the chambers of the heart). Without contact-force sensing technology, physicians have to estimate by touch with their hands the amount of force applied to the heart wall during an ablation. If too little force is applied, effective lesions may not be created and Afib may recur, potentially requiring additional treatments. When too much force is applied, there is risk of tissue injury, which can lead to serious procedure-related complications.
An estimated 2.7 million people are impacted by Afib, making the condition the most common type of arrhythmia affecting Americans today. Afib is a progressive disease that increases in severity and frequency if left untreated, and can lead to chronic fatigue, congestive heart failure and stroke.
KOAT medical expert Dr. Barry Ramo was honored by Albuquerque’s mayor Friday for the live-saving program he started.
“Your hard work and ingenuity to save lives makes you a champion for our community. Dr. Ramo, thank you very much. We appreciate all of your hard work,” Mayor Richard Berry said.
Project Heart Start is a hands only CPR program that Dr. Ramo started in 2010. So far, 25,000 have taken the free training and it has saved many lives in New Mexico.